Courses & Units
Advanced Pharmacotherapeutics in Psychiatric and Neurological Disorders CSA726
Hobart
Introduction
CSA726 is a self-directed, fully on-line unit, that explores a variety of disease states and their management, using a series of patient cases linked to assignment based questions, to enable the student to enhance their knowledge in the area of clinical pharmacy and pharmaceutical care.
Summary
| Unit name | Advanced Pharmacotherapeutics VI |
|---|---|
| Unit code | CSA726 |
| Credit points | 12.5 |
| College/School | College of Health and Medicine School of Pharmacy and Pharmacology |
| Discipline | Pharmacy |
| Coordinator | Doctor Mohammed Salahudeen |
| Teaching staff | Ms Naomi Weier |
| Delivered By | Delivered wholly by the provider |
| Level | Postgraduate |
Availability
This unit is currently unavailable.
Key Dates
| Study Period | Start date | Census date | WW date | End date |
|---|---|---|---|---|
| Semester 2 | 12/7/2021 | 10/8/2021 | 30/8/2021 | 17/10/2021 |
| Semester 1 | 22/2/2021 | 23/3/2021 | 12/4/2021 | 30/5/2021 |
* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (refer to How do I withdraw from a unit? for more information).
Unit census dates currently displaying for 2021 are indicative and subject to change. Finalised census dates for 2021 will be available from the 1st October 2020. Note census date cutoff is 11.59pm AEST (AEDT during October to March).
Learning Outcomes
- Identify and evaluate problems associated with psychiatric and neurological medications using an evidence-based approach
- Critically evaluate psychiatric and neurological medication therapy using an evidence-based approach and accepted best clinical practice to devise and justify appropriate courses of action for therapeutic management.
- Employ evidence-based and contemporary clinical skills to conduct a clinical audit and demonstrate how this may influence pharmacy practice in the management of psychiatric and neurological diseases.
- Demonstrate effective written and oral presentation skills to explain contemporary issues associated with psychiatric and neurological medication therapy.
Fee Information
| Field of Education | Commencing Student Contribution 1,3 | Grandfathered Student Contribution 1,3 | Approved Pathway Course Student Contribution 2,3 | Domestic Full Fee 4 |
|---|---|---|---|---|
| 019907 | $993.00 | $993.00 | not applicable | $2,354.00 |
- Available as a Commonwealth Supported Place
- HECS-HELP is available on this unit, depending on your eligibility3
- FEE-HELP is available on this unit, depending on your eligibility4
1 Please refer to more information on student contribution amounts.
2 Please refer to more information on eligibility and Approved Pathway courses.
3 Please refer to more information on eligibility for HECS-HELP.
4 Please refer to more information on eligibility for FEE-HELP.
If you have any questions in relation to the fees, please contact UConnect or more information is available on StudyAssist.
Please note: international students should refer to What is an indicative Fee? to get an indicative course cost.
Requisites
Concurrent Prerequisites
CSA721Teaching
| Assessment | Test or quiz (5%)|Poster presentation (20%)|Assignment (15%)|Assignment (25%)|Case Study (35%) |
|---|---|
| Timetable | View the lecture timetable | View the full unit timetable |
Textbooks
| Required |
Required readings will be listed in the unit outline prior to the start of classes. |
Links | Booktopia textbook finder |
|---|
The University reserves the right to amend or remove courses and unit availabilities, as appropriate.